INCOME STATEMENT
Venus Remedies Ltd.
BSE
Apr 30
304.85
-6.30 ( -2.02%)
Volume
1078
Prev. Close
311.15
Open Price
315.35
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
302.85
-8.70 ( -2.79%)
Volume
22329
Prev. Close
311.55
Open Price
315.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE411B01019
|
Market Cap. ( ₹ in Cr. )
|
404.82
|
P/BV
|
0.82
|
Book Value ( ₹ )
|
369.73
|
|
BSE Code
|
526953
|
52 Week High/Low ( ₹ )
|
428/270
|
FV/ML
|
10/1
|
P/E(X)
|
14.21
|
|
NSE Code
|
VENUSREMEQ
|
Book Closure
|
23/09/2024
|
EPS ( ₹ )
|
21.31
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 565.21 | 535.53 | 575.18 | 507.00 | 315.40 |
| Other Operating Revenues | 10.00 | 2.13 | 0.00 | 7.62 | 4.83 |
| Total Operating Revenues | 575.21 | 537.66 | 575.18 | 514.62 | 320.23 |
| | | | | | |
| Other Income | 11.32 | 10.17 | 8.43 | 17.76 | 3.58 |
| Total Revenue | 586.53 | 547.84 | 583.61 | 532.39 | 323.81 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 344.15 | 317.28 | 372.78 | 344.04 | 170.60 |
| Purchase Of Stock-In Trade | 13.07 | 5.16 | 0.00 | 0.00 | 0.00 |
| Operating And Direct Expenses | 14.59 | 10.17 | 9.85 | 7.74 | 6.88 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -5.00 | 14.26 | 3.19 | -7.36 | 6.21 |
| Employee Benefit Expenses | 62.13 | 51.95 | 43.75 | 35.89 | 33.79 |
| Finance Costs | 0.00 | 0.00 | 0.00 | 12.73 | 13.05 |
| Depreciation And Amortisation Expenses | 25.55 | 31.37 | 32.58 | 34.28 | 31.05 |
| Other Expenses | 85.38 | 77.31 | 76.80 | 87.44 | 59.68 |
| Total Expenses | 539.88 | 507.51 | 538.94 | 514.77 | 321.26 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 46.65 | 40.33 | 44.67 | 17.62 | 2.55 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 23.44 | -8.81 |
| Profit/Loss Before Tax | 46.65 | 40.33 | 44.67 | 41.06 | -6.26 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 11.74 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.93 | 11.36 | -4.32 | -13.21 | 1.96 |
| Tax For Earlier Years | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | 16.15 | 11.36 | -4.32 | -13.21 | 1.96 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 30.50 | 28.96 | 48.99 | 54.27 | -8.23 |
| | | | | | |
| Profit/Loss From Continuing Operations | 30.50 | 28.96 | 48.99 | 54.27 | -8.23 |
| | | | | | |
| Profit/Loss For The Period | 30.50 | 28.96 | 48.99 | 54.27 | -8.23 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 22.82 | 21.67 | 37.12 | 43.97 | -6.67 |
| Diluted EPS (Rs.) | 22.82 | 21.67 | 37.12 | 43.97 | -6.67 |